A one-dose oral drug called zoliflodacin has proven highly effective against gonorrhoea in a major international trial. The ...

Rochelle Collins, DO, is a board-certified family medicine physician and assistant clinical professor of family medicine at Quinnipiac University. Discharge from your belly button might be a sign of ...

The U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea. The first approval is for Nuzolvence (zoliflodacin) granules that ...

FDA Approves Two New Antibiotics to Treat Drug-Resistant Gonorrhea MONDAY, Dec. 15, 2025 (HealthDay News) — Doctors now have new tools to fight gonorrhea, a common sexually transmitted infection that ...

Dec 12 (Reuters) - The U.S. health regulator on Friday approved Innoviva's (INVA.O), opens new tab oral antibiotic to treat gonorrhea, a common sexually transmitted infection, offering patients an ...

For the first time in decades, the U.S. Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection ...

After a three-decade drought of new antibiotics to treat gonorrhea, the FDA has signed off on two first-in-class oral treatments for the sexually transmitted infection (STI), which affects more than ...

With an increase in the antimicrobial resistance to therapies for gonorrhea, doctors have been left with fewer options to treat the sexually transmitted infection (STI), which strikes more an 80 ...

The FDA has approved GSK's gepotidacin (Blujepa), the first new antibiotic class for gonorrhea in over three decades, offering a crucial option amid rising drug resistance. Phase 3 EAGLE-1 trial ...

The sexually transmitted disease has become increasingly resistant to existing antibiotics. By Andrew Jacobs The Food and Drug Administration has approved two new antibiotics for the treatment of ...

Please provide your email address to receive an email when new articles are posted on . Gonorrhea has become increasingly resistant to existing antibiotics. Two newly approved drugs, gepotidacin and ...